{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:05:38Z","timestamp":1781499938462,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ctrv.2020.102058","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T21:47:40Z","timestamp":1592516860000},"page":"102058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Isolated limb perfusion for soft tissue sarcoma: Current practices and future directions. A survey of experts and a review of literature"],"prefix":"10.1016","volume":"88","author":[{"given":"K.S.","family":"Martin-Tellez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"van Coevorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2020.102058_b0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1634\/theoncologist.2007-0165","article-title":"Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?","volume":"13","author":"Hohenberger","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2020.102058_b0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-006-9251-1","article-title":"Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution","volume":"14","author":"Pennacchioli","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000658-198209000-00009","article-title":"The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy","volume":"196","author":"Rosenberg","year":"1982","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2020.102058_b0020","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199612000-00011","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience","volume":"224","author":"Eggermont","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2020.102058_b0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit","volume":"148","author":"Creech","year":"1958","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2020.102058_b0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00000658-195010000-00018","article-title":"Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report","volume":"132","author":"Klopp","year":"1950","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2020.102058_b0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1992.10.1.52","article-title":"High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma","volume":"10","author":"Lienard","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0040","doi-asserted-by":"crossref","unstructured":"Hoekstra HJ. Isolated limb perfusion. In: Atlas of procedures in surgical onoclogy with critical, evidence-based commentary notes. Singapore: World Scientific Publishing Co, Pte, Ltd; 2009.","DOI":"10.1142\/9789812832948_0036"},{"key":"10.1016\/j.ctrv.2020.102058_b0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02656736.2015.1101170","article-title":"Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience","volume":"32","author":"Rastrelli","year":"2016","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ctrv.2020.102058_b0050","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/cncr.25850","article-title":"Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials","volume":"117","author":"Wray","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1245\/ASO.2004.12.042","article-title":"Isolated limb perfusion: what is the evidence for its use?","volume":"11","author":"Noorda","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ctrv.2012.10.005","article-title":"Isolated limb perfusion of soft tissue sarcomas: a comprehensive review of literature","volume":"39","author":"Seinen","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctrv.2020.102058_b0065","first-page":"2631","article-title":"Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells","volume":"47","author":"Hansson","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2020.102058_b0070","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E","article-title":"A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma","volume":"55","author":"Minor","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00008390-200112000-00007","article-title":"Saturable dose-response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat","volume":"11","author":"Roberts","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ctrv.2020.102058_b0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11912-001-0090-8","article-title":"Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives","volume":"3","author":"Eggermont","year":"2001","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ctrv.2020.102058_b0085","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1054\/bjoc.1999.1032","article-title":"Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion","volume":"82","author":"de Wilt","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1245\/s10434-006-9040-x","article-title":"Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma","volume":"14","author":"Hayes","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejso.2008.01.007","article-title":"Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma","volume":"35","author":"Nachmany","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/nbm.1940080506","article-title":"31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF-alpha + melphalan isolated limb perfusion","volume":"8","author":"Sijens","year":"1995","journal-title":"NMR Biomed"},{"issue":"821\u2013832","key":"10.1016\/j.ctrv.2020.102058_b0105","first-page":"ix","article-title":"Isolated limb perfusion: the European experience","volume":"10","author":"Lejeune","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ctrv.2020.102058_b0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ijc.2910570508","article-title":"Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha)","volume":"57","author":"Renard","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00001622-200307000-00004","article-title":"Hyperthermic isolated limb perfusion in the management of extremity sarcoma","volume":"15","author":"Hoekstra","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdi229","article-title":"Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?","volume":"16","author":"Bonvalot","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0125","first-page":"171","article-title":"The biologic rationale of hyperthermia","volume":"134","author":"Hildebrandt","year":"2007","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ctrv.2020.102058_b0130","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#","article-title":"Selective heat sensitivity of cancer cells. Biochemical and clinical studies","volume":"20","author":"Cavaliere","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/02656730210123534","article-title":"Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro","volume":"18","author":"Urano","year":"2002","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ctrv.2020.102058_b0140","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(03)01141-0","article-title":"Current uses of isolated limb perfusion in the clinic and a model system for new strategies","volume":"4","author":"Eggermont","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0145","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/j.1875-9114.2012.01108.x","article-title":"Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults","volume":"32","author":"Pai","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ctrv.2020.102058_b0150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1477-7819-12-81","article-title":"Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation","volume":"12","author":"Podleska","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0160","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1245\/s10434-008-9988-9","article-title":"Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion","volume":"15","author":"Beasley","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0165","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.ejso.2016.02.250","article-title":"Calculating regional tissue volume for hyperthermic isolated limb perfusion: Four methods compared","volume":"42","author":"Cecchin","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1992.235","article-title":"The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma","volume":"66","author":"Scott","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0175","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jso.21885","article-title":"TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome","volume":"103","author":"Hoven-Gondrie","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0180","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.1800831004","article-title":"Thirty-five years of isolated limb perfusion for melanoma: indications and results","volume":"83","author":"Vrouenraets","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctrv.2020.102058_b0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/030089160108700314","article-title":"Deep venous thrombosis of the extremity diagnosed by color Doppler ultrasonography after isolated limb perfusion","volume":"87","author":"Eroglu","year":"2001","journal-title":"Tumori"},{"key":"10.1016\/j.ctrv.2020.102058_b0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02656730701805520","article-title":"Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma","volume":"24","author":"Moller","year":"2008","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ctrv.2020.102058_b0195","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/BF02303810","article-title":"Functional morbidity of hyperthermic isolated regional perfusion of the extremities","volume":"1","author":"Olieman","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0200","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.21802","article-title":"Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma","volume":"106","author":"Grunhagen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10434-000-0155-1","article-title":"Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations","volume":"7","author":"Issakov","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1634\/theoncologist.2007-0220","article-title":"Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation","volume":"13","author":"Lucas","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2020.102058_b0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jso.23775","article-title":"Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma","volume":"111","author":"Vaynrub","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0220","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1245\/s10434-012-2408-1","article-title":"Size-based clinical response evaluation is insufficient to assess clinical response of sarcomas treated with isolated limb perfusion with TNF-alpha and melphalan","volume":"19","author":"Grabellus","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.ctrv.2020.102058_b0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1634\/theoncologist.13-S2-32","article-title":"Selection of response criteria for clinical trials of sarcoma treatment","volume":"13","author":"Schuetze","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2020.102058_b0230","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2015.09.021","article-title":"Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting","volume":"53","author":"Wardelmann","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2018.05.011","article-title":"Histopathological tumor response following neoadjuvant hyperthermic isolated limb perfusion in extremity soft tissue sarcomas: Evaluation of the EORTC-STBSG response score","author":"Stevenson","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0245","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1245\/s10434-017-6109-7","article-title":"Isolated limb perfusion and infusion for extremity soft tissue sarcoma: A contemporary systematic review and meta-analysis","volume":"24","author":"Neuwirth","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0250","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/jso.23200","article-title":"Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials","volume":"106","author":"Trabulsi","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejso.2012.12.018","article-title":"Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review","volume":"39","author":"Bhangu","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0260","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1200\/JCO.2011.35.6618","article-title":"Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas","volume":"29","author":"Deroose","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13569-018-0098-6","article-title":"Regional chemotherapy by isolated limb perfusion prior to surgery compared with surgery and post-operative radiotherapy for primary, locally advanced extremity sarcoma: a comparison of matched cohorts","volume":"8","author":"Jakob","year":"2018","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.ctrv.2020.102058_b0270","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1245\/s10434-010-1461-x","article-title":"ILP and RT: the study that will never be","volume":"18","author":"Bonvalot","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2018.04.012","article-title":"Fractures after multimodality treatment of soft tissue sarcomas with isolated limb perfusion and radiation; likely to occur and hard to heal","author":"Seinen","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1245\/s10434-010-1400-x","article-title":"Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?","volume":"18","author":"Deroose","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0285","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1245\/ASO.2006.02.005","article-title":"Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy","volume":"13","author":"Thijssens","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0290","doi-asserted-by":"crossref","unstructured":"Huis In 't Veld EA, Grunhagen DJ, Verhoef C et al. Isolated limb perfusion for locally advanced angiosarcoma in extremities: A multi-centre study. Eur J Cancer 2017; 85: 114\u2013121.","DOI":"10.1016\/j.ejca.2017.07.023"},{"key":"10.1016\/j.ctrv.2020.102058_b0295","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2018.04.014","article-title":"The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies","volume":"100","author":"Smith","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejso.2016.09.021","article-title":"Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes","volume":"43","author":"Rastrelli","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0305","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-007-9365-0","article-title":"Long-term locoregional vascular morbidity after isolated limb perfusion and external-beam radiotherapy for soft tissue sarcoma of the extremity","volume":"14","author":"Hoven-Gondrie","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0310","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-18-3767","article-title":"PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma","volume":"25","author":"Smith","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2020.102058_b0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejso.2015.08.165","article-title":"The role of regional chemotherapy in the management of extremity soft tissue malignancies","volume":"42","author":"Smith","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2020.102058_b0320","doi-asserted-by":"crossref","first-page":"81208","DOI":"10.18632\/oncotarget.12820","article-title":"Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis","volume":"7","author":"Wilkinson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2020.102058_b0325","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ijc.29059","article-title":"Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma","volume":"136","author":"Pencavel","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2020.102058_b0330","unstructured":"TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion) (TITAN). In. NCT03555032."},{"key":"10.1016\/j.ctrv.2020.102058_b0335","doi-asserted-by":"crossref","unstructured":"Eggermont AM, Brunstein F, Grunhagen D, ten Hagen TL. Regional treatment of metastasis: role of regional perfusion. State of the art isolated limb perfusion for limb salvage. Ann Oncol 2004; 15 Suppl 4: iv107-112.","DOI":"10.1093\/annonc\/mdh913"},{"key":"10.1016\/j.ctrv.2020.102058_b0340","first-page":"794","article-title":"Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas","volume":"54","author":"Cordon-Cardo","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2020.102058_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038808","article-title":"Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-alpha by restoring p53 function","volume":"7","author":"Muret","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220300967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737220300967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:24:17Z","timestamp":1759656257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737220300967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":69,"alternative-id":["S0305737220300967"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.102058","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated limb perfusion for soft tissue sarcoma: Current practices and future directions. A survey of experts and a review of literature","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2020.102058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102058"}}